Hence, the present study aimed to explore correlations between Ki67 levels and the efficacy of adjuvant chemotherapy in MM as well as to provide an accurate basis for selecting the optimal population for adjuvant therapy. This evidence concerns the gene MKI67 and Miyoshi myopathy.